Chuah Shin Chet, Moore Philip K, Zhu Yi Zhun
Cardiovascular Biology Research Group, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, China.
Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H2693-701. doi: 10.1152/ajpheart.00853.2007. Epub 2007 Aug 31.
S-allylcysteine (SAC) is an organosulfur-containing compound derived from garlic. Studies have shown that garlic is beneficial in the treatment of cardiovascular diseases. This study aims to elucidate if SAC is responsible for this cardioprotection using acute myocardial infarction (AMI) rat models. In addition, we hypothesized that SAC may mediate cardioprotection via a hydrogen sulfide (H(2)S)-related pathway. Rats were pretreated with saline, SAC (50 mg x kg(-1) x day(-1)), SAC + propagylglycine (PAG; 50 mg + 10 mg x kg(-1) x day(-1)) or PAG (10 mg x kg(-1) x day(-1)) for 7 days before AMI induction and killed 48 h after. Our results showed that SAC significantly lowered mortality (12.5% vs. 33.3%, P < 0.05) and reduced infarct size. SAC + PAG- and PAG-treated rats had larger infarct sizes than controls (60.9 +/- 0.01 and 62.0 +/- 0.03%, respectively, vs. 50.0 +/- 0.03%; P < 0.05). Pretreatment with SAC did not affect BP, but BP was significantly elevated in SAC + PAG and PAG-treated groups (P < 0.05). In addition, plasma H(2)S levels and left ventricular cystathionine-gamma-lyase (CSE) activities were analyzed to investigate the involvement of H(2)S. CSE is the enzyme responsible for H(2)S production in the heart. SAC increased left ventricular CSE activity in AMI rats (2.75 +/- 0.34 vs. 1.23 +/- 0.16 micromol x g protein(-1) x h(-1); P < 0.01). SAC + PAG-treated rats had significantly lower CSE activity compared with the SAC-treated group (1.22 +/- 0.27 vs. 2.75 +/- 0.34 micromol x g protein(-1) x h(-1); P < 0.05). Similarly, SAC-treated rats had higher plasma H(2)S concentration compared with controls and the SAC + PAG-treated group. Protein expression studies revealed that SAC upregulated CSE expression (1.1-fold of control; P < 0.05), whereas SAC + PAG and PAG downregulated its expression (0.88-fold of control in both groups; P < 0.005). In conclusion, our study provides novel evidence that SAC is protective in myocardial infarction via an H(2)S-related pathway.
S-烯丙基半胱氨酸(SAC)是一种源自大蒜的含有机硫化合物。研究表明,大蒜对心血管疾病的治疗有益。本研究旨在使用急性心肌梗死(AMI)大鼠模型阐明SAC是否对这种心脏保护作用负责。此外,我们假设SAC可能通过与硫化氢(H₂S)相关的途径介导心脏保护作用。在诱导AMI前7天,大鼠分别用生理盐水、SAC(50mg·kg⁻¹·天⁻¹)、SAC + 炔丙基甘氨酸(PAG;50mg + 10mg·kg⁻¹·天⁻¹)或PAG(10mg·kg⁻¹·天⁻¹)进行预处理,并在48小时后处死。我们的结果表明,SAC显著降低了死亡率(12.5%对33.3%,P < 0.05)并减小了梗死面积。SAC + PAG组和PAG处理组的大鼠梗死面积比对照组大(分别为60.9±0.01%和62.0±0.03%,对50.0±0.03%;P < 0.05)。SAC预处理不影响血压,但SAC + PAG组和PAG处理组的血压显著升高(P < 0.05)。此外,分析血浆H₂S水平和左心室胱硫醚-γ-裂解酶(CSE)活性以研究H₂S的参与情况。CSE是心脏中负责产生H₂S的酶。SAC增加了AMI大鼠左心室CSE活性(2.75±0.34对1.23±0.16μmol·g蛋白⁻¹·小时⁻¹;P < 0.01)。与SAC处理组相比,SAC + PAG处理组的大鼠CSE活性显著降低(1.22±0.27对2.75±0.34μmol·g蛋白⁻¹·小时⁻¹;P < 0.05)。同样,与对照组和SAC + PAG处理组相比,SAC处理组的大鼠血浆H₂S浓度更高。蛋白质表达研究表明,SAC上调了CSE表达(为对照组的1.1倍;P < 0.05),而SAC + PAG组和PAG组下调了其表达(两组均为对照组的0.88倍;P < 0.005)。总之,我们的研究提供了新的证据,表明SAC通过与H₂S相关的途径对心肌梗死具有保护作用。